BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Report

MERCK & CO.

via THE CACTUS GROUP, LLC

3rd Quarter (July 1 - Sep 30) · 2019Posted Oct 11, 2019Filing document ↗LDA record ↗

Income$15Kfee reported

Client

Name: MERCK & CO.
Description: Pharmaceutical manufacturer
Location: District of Columbia · United States of America

Registrant

Firm: THE CACTUS GROUP, LLC
Description: Contractor for federal lobbying
Location: Arlington, Virginia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
HR 5712 - Medicaid Drug Rebate Accountability Act - bill in its entirety (oppose)
LobbyistsSUSAN AUTHER ANDRES
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

MERCK & CO. — Lobbying — Receipts Report